|
The German company, TeGenero, which made the drug that left six people seriously ill during a clinical trial, has filed for insolvency.
The six men suffered organ failure after taking part in the drug trial at Northwick Park Hospital, north-west London, in March. Two others taking placebos were unharmed.
The company said their "unforeseeable adverse reactions" in trials of the drug TGN1412, manufactured as a treatment for rheumatoid arthritis, leukaemia and multiple sclerosis, "have made it impossible to attract the investment necessary for the company to continue operations".
Ann Alexander of law firm Irwin Mitchell, which represents two of the men, said: "I am not surprised that this company has filed for insolvency. However, I am surprised they have chosen to do so before the compensation claims were even considered, thereby causing further alarm and psychological distress for our clients”.
|
|